Table 3.

Comparative analysis of biochemical parameters between HF patients without complications, with thrombosis and bleeding complications.

Study Groups	Parameters	Before 14 Days	p-Value	After 3–6 Months	p-Value	After 12–18 Month	p-Value
Group 1	Hemoglobin, g/L	139.6 ± 18.2		129.5 ± 16.2		125.7 ± 20.0
Group 2-1		145.8 ± 21.7	0.32 *	129.0 ± 15.3	0.93 *	125.1 ± 18.4	0.95 *
Group 2-2		128.5 ± 21.2	0.052 *	111.1 ± 29.2	0.04 **	117.6 ± 35.0	0.55 *
Group 1	Hematocrit, %	41.1 ± 6.72		38.2 ± 4.92		37.5 ± 5.46
Group 2-1		43.1 ± 6.95	0.39 *	37.0 ± 3.67	0.51 *	36.3 ± 6.14	0.58 *
Group 2-2		39.0 ± 6.61	0.30 *	32.8 ± 8.70	0.016 *	35.6 ± 10.3	0.63 *
Group 1	Lymphocytes, %	27.5 ± 9.25		26.2 ± 8.79		22.0 ± 6.44
Group 2-1		31.0 ± 8.78	0.19 **	18.4 ± 6.34	0.015 *	29.8 ± 11.3	0.03 **
Group 2-2		21.8 ± 6.28	0.02 **	24.8 ± 9.35	0.68 *	19.9 ± 11.3	0.27 **
Group 1	LDH, U/L	271.5 ± 137.0		273.5 ± 93.7		306.0 ± 156.1
Group 2-1		N/A		335.4 ± 133.3	0.24 **	194.6 ± 42.7	0.02 **
Group 2-2		254.0 ± 171.9	0.38 **	260.2 ± 139.0	0.78 *	377.4 ± 174.2	0.19 **
Group 1	AST, U/L	27.9 ± 21.4		19.6 ± 5.50		21.2 ± 8.08
Group 2-1		29.5 ± 10.6	0.11 **	26.9 ± 19.0	0.42 **	22.2 ± 8.44	0.77 *
Group 2-2		33.3 ± 27.0	0.43 **	36.9 ± 37.5	0.02 **	43.0 ± 70.3	0.63 **
Group 1	Total bilirubin, mg/dL	1.33 ± 1.56		0.70 ± 0.51		1.03 ± 1.51
Group 2-1		1.03 ± 0.73	0.74 **	1.26 ± 0.58	0.01 **	0.76 ± 0.80	0.55 **
Group 2-2		3.00 ± 5.09	0.40 **	1.59 ± 2.76	0.77 **	0.96 ± 0.71	0.42 **

Continuous variables are presented, mean ± SD. Student’s t-test p-value is labeled with one asterisk (*); Mann-Whitney U test’s p-value is labeled with double asterisks (**); the significant p value (p < 0.05) is labeled in bold; N/A, Not available. Group 1, without complications; Group 2-1, thrombosis; Group 2-2, bleeding; LDH, lactate dehydrogenase; AST, aspartate aminotransferase.